Picture of Daito Pharmaceutical logo

4577 — Daito Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeSmall CapSuper Stock

Table: Daito -2024/25 parent results

Jul 11 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to     NEXT     
              May 31, 2025    May 31, 2024   May 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           50.44           46.59                                
               (+8.3 pct)      (+4.2 pct)                              
  Operating        2.36            3.79                                
               (-37.7 pct)     (-24.6 pct)                             
  Recurring        2.50            3.87                                
               (-35.5 pct)     (-23.8 pct)                             
  Net              1.51            3.25                                
               (-53.4 pct)     (-6.9 pct)                              
  EPS           49.74 yen      103.54 yen                              
  Ann Div       70.00 yen       60.00 yen      40.00 yen               
  -Q2 Div       35.00 yen       30.00 yen      20.00 yen               
  -Q4 Div       35.00 yen       30.00 yen      20.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T

Recent news on Daito Pharmaceutical

See all news